Skip to main content
Top
Published in: Journal of Nuclear Cardiology 5/2020

01-10-2020 | Original Article

Comparison of two dipyridamole infusion protocols for myocardial perfusion imaging in subjects with low likelihood of significant obstructive coronary artery disease

Authors: Francois Harel, MD, PhD, FRCPC, Vincent Finnerty, MSc, Sébastien Authier, BEng, Matthieu Pelletier-Galarneau, MD, MSc, FRCPC

Published in: Journal of Nuclear Cardiology | Issue 5/2020

Login to get access

Abstract

Background

Myocardial perfusion imaging (MPI) with positron emission tomography allows accurate measurements of myocardial blood flow (MBF). Stress MBF thresholds have been proposed to provide diagnostic and prognostic information in different pathology. Most studies relying on dipyridamole use a 5-minute infusion protocol, while current guidelines recommend a 4-minute infusion. The purpose of this study is to compare the effects of different dipyridamole infusion times on stress MBF.

Methods

The charts of 2,207 patients who underwent rubidium-82 MPI were retrospectively reviewed and 147 subjects with low likelihood of significant coronary artery disease (CAD) defined as calcium score = 0, body mass index < 45 kg·m−2, and summed stress score ≤ 3 were included. Of those, 65 were imaged with a 4-minute dipyridamole infusion (0.56 mg·kg−1) protocol and 82 with a 5-minute protocol (0.70 mg·kg−1).

Results

Stress MBF (3.23±0.76 vs 3.02±0.71 mL·min−1·g−1, P = 0.09), myocardial flow reserve (2.70±0.67 vs 2.85±0.74, P = 0.20), and coronary vascular resistance index (30±10 vs 31±9 mmHg × g × min·mL−1, P = 0.38) were not significantly different between the two protocols. The 5-minute protocol was associated with higher prevalence of symptoms (92.7% vs 81.5%, P = 0.04) and greater decrease in systolic blood pressure (− 9 vs − 6 mmHg, P = 0.03).

Conclusions

The 4-minute and 5-minute dipyridamole infusion protocols produce comparable myocardial flow response, hemodynamic changes, and symptoms, in subjects with low likelihood of significant obstructive CAD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Henzlova MJ, Duvall WL, Einstein AJ, Travin MI, Verberne HJ. ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers. J Nucl Cardiol. 2016;23:606-39.CrossRef Henzlova MJ, Duvall WL, Einstein AJ, Travin MI, Verberne HJ. ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers. J Nucl Cardiol. 2016;23:606-39.CrossRef
2.
go back to reference Dal Porto R, Faletra F, Picano E, Pirelli S, Moreo A, Varga A. Safety, feasibility, and diagnostic accuracy of accelerated high-dose dipyridamole stress echocardiography. Am J Cardiol. 2001;87:520-4.CrossRef Dal Porto R, Faletra F, Picano E, Pirelli S, Moreo A, Varga A. Safety, feasibility, and diagnostic accuracy of accelerated high-dose dipyridamole stress echocardiography. Am J Cardiol. 2001;87:520-4.CrossRef
3.
go back to reference Salustri A, Fioretti PM, McNeill AJ, Pozzoli MM, Roelandt JR. Pharmacological stress echocardiography in the diagnosis of coronary artery disease and myocardial ischaemia: A comparison between dobutamine and dipyridamole. Eur Heart J. 1992;13:1356-62.CrossRef Salustri A, Fioretti PM, McNeill AJ, Pozzoli MM, Roelandt JR. Pharmacological stress echocardiography in the diagnosis of coronary artery disease and myocardial ischaemia: A comparison between dobutamine and dipyridamole. Eur Heart J. 1992;13:1356-62.CrossRef
4.
go back to reference San Román JA, Vilacosta I, Castillo JA, Rollán MJ, Peral V, Sánchez-Harguindey L, et al. Dipyridamole and dobutamine-atropine stress echocardiography in the diagnosis of coronary artery disease. Comparison with exercise stress test, analysis of agreement, and impact of antianginal treatment. Chest. 1996;110:1248-54.CrossRef San Román JA, Vilacosta I, Castillo JA, Rollán MJ, Peral V, Sánchez-Harguindey L, et al. Dipyridamole and dobutamine-atropine stress echocardiography in the diagnosis of coronary artery disease. Comparison with exercise stress test, analysis of agreement, and impact of antianginal treatment. Chest. 1996;110:1248-54.CrossRef
5.
go back to reference Bodi V, Husser O, Sanchis J, Núñez J, Monmeneu JV, López-Lereu MP, et al. Prognostic implications of dipyridamole cardiac MR imaging: A prospective multicenter registry. Radiology. 2012;262:91-100.CrossRef Bodi V, Husser O, Sanchis J, Núñez J, Monmeneu JV, López-Lereu MP, et al. Prognostic implications of dipyridamole cardiac MR imaging: A prospective multicenter registry. Radiology. 2012;262:91-100.CrossRef
6.
go back to reference Bodi V, Sanchis J, Lopez-Lereu MP, Nunez J, Mainar L, Monmeneu JV, et al. Prognostic and therapeutic implications of dipyridamole stress cardiovascular magnetic resonance on the basis of the ischaemic cascade. Heart. 2009;95:49-55.CrossRef Bodi V, Sanchis J, Lopez-Lereu MP, Nunez J, Mainar L, Monmeneu JV, et al. Prognostic and therapeutic implications of dipyridamole stress cardiovascular magnetic resonance on the basis of the ischaemic cascade. Heart. 2009;95:49-55.CrossRef
7.
go back to reference Gerber BL, Raman SV, Nayak K, Epstein FH, Ferreira P, Axel L, et al. Myocardial first-pass perfusion cardiovascular magnetic resonance: History, theory, and current state of the art. J Cardiovasc Magn Reson. 2008;10:18.CrossRef Gerber BL, Raman SV, Nayak K, Epstein FH, Ferreira P, Axel L, et al. Myocardial first-pass perfusion cardiovascular magnetic resonance: History, theory, and current state of the art. J Cardiovasc Magn Reson. 2008;10:18.CrossRef
8.
go back to reference Paz Y, Morgenstern R, Weinberg R, Chiles M, Bhatti N, Ali Z, et al. Relation of coronary flow reserve to other findings on positron emission tomography myocardial perfusion imaging and left heart catheterization in patients with end-stage renal disease being evaluated for kidney transplant. Am J Cardiol. 2017;120:1909-12.CrossRef Paz Y, Morgenstern R, Weinberg R, Chiles M, Bhatti N, Ali Z, et al. Relation of coronary flow reserve to other findings on positron emission tomography myocardial perfusion imaging and left heart catheterization in patients with end-stage renal disease being evaluated for kidney transplant. Am J Cardiol. 2017;120:1909-12.CrossRef
9.
go back to reference Witbrodt B, Goyal A, Kelkar AA, Dorbala S, Chow BJW, Di Carli MF, et al. Prognostic significance of blood pressure response during vasodilator stress Rb-82 positron emission tomography myocardial perfusion imaging. J Nucl Cardiol. 2017;24:1966-75.CrossRef Witbrodt B, Goyal A, Kelkar AA, Dorbala S, Chow BJW, Di Carli MF, et al. Prognostic significance of blood pressure response during vasodilator stress Rb-82 positron emission tomography myocardial perfusion imaging. J Nucl Cardiol. 2017;24:1966-75.CrossRef
10.
go back to reference Hussain N, Chaudhry W, Ahlberg AW, Amara RS, Elfar A, Parker MW, et al. An assessment of the safety, hemodynamic response, and diagnostic accuracy of commonly used vasodilator stressors in patients with severe aortic stenosis. J Nucl Cardiol. 2017;24:1200-13.CrossRef Hussain N, Chaudhry W, Ahlberg AW, Amara RS, Elfar A, Parker MW, et al. An assessment of the safety, hemodynamic response, and diagnostic accuracy of commonly used vasodilator stressors in patients with severe aortic stenosis. J Nucl Cardiol. 2017;24:1200-13.CrossRef
11.
go back to reference Li Y, Chahal N, Senior R, Tang M-X. Reproducible computer-assisted quantification of myocardial perfusion with contrast-enhanced ultrasound. Ultrasound Med Biol. 2017;43:2235-46.CrossRef Li Y, Chahal N, Senior R, Tang M-X. Reproducible computer-assisted quantification of myocardial perfusion with contrast-enhanced ultrasound. Ultrasound Med Biol. 2017;43:2235-46.CrossRef
12.
go back to reference Mygind ND, Michelsen MM, Pena A, Qayyum AA, Frestad D, Christensen TE, et al. Coronary microvascular function and myocardial fibrosis in women with angina pectoris and no obstructive coronary artery disease: The iPOWER study. J Cardiovasc Magn Reson. 2016;18:76.CrossRef Mygind ND, Michelsen MM, Pena A, Qayyum AA, Frestad D, Christensen TE, et al. Coronary microvascular function and myocardial fibrosis in women with angina pectoris and no obstructive coronary artery disease: The iPOWER study. J Cardiovasc Magn Reson. 2016;18:76.CrossRef
13.
go back to reference Vijarnsorn C, Noga M, Schantz D, Pepelassis D, Tham EB. Stress perfusion magnetic resonance imaging to detect coronary artery lesions in children. Int J Cardiovasc Imaging. 2017;33:699-709.CrossRef Vijarnsorn C, Noga M, Schantz D, Pepelassis D, Tham EB. Stress perfusion magnetic resonance imaging to detect coronary artery lesions in children. Int J Cardiovasc Imaging. 2017;33:699-709.CrossRef
14.
go back to reference Jeremias A, Filardo SD, Whitbourn RJ, Kernoff RS, Yeung AC, Fitzgerald PJ, et al. Effects of intravenous and intracoronary adenosine 5′-triphosphate as compared with adenosine on coronary flow and pressure dynamics. Circulation. 2000;101:318-23.CrossRef Jeremias A, Filardo SD, Whitbourn RJ, Kernoff RS, Yeung AC, Fitzgerald PJ, et al. Effects of intravenous and intracoronary adenosine 5′-triphosphate as compared with adenosine on coronary flow and pressure dynamics. Circulation. 2000;101:318-23.CrossRef
15.
go back to reference Czernin J, Auerbach M, Sun KT, Phelps M, Schelbert HR. Effects of modified pharmacologic stress approaches on hyperemic myocardial blood flow. J Nucl Med. 1995;36:575-80. Czernin J, Auerbach M, Sun KT, Phelps M, Schelbert HR. Effects of modified pharmacologic stress approaches on hyperemic myocardial blood flow. J Nucl Med. 1995;36:575-80.
16.
go back to reference Lortie M, Beanlands RSB, Yoshinaga K, Klein R, Dasilva JN, DeKemp RA. Quantification of myocardial blood flow with 82Rb dynamic PET imaging. Eur J Nucl Med Mol Imaging. 2007;34:1765-74.CrossRef Lortie M, Beanlands RSB, Yoshinaga K, Klein R, Dasilva JN, DeKemp RA. Quantification of myocardial blood flow with 82Rb dynamic PET imaging. Eur J Nucl Med Mol Imaging. 2007;34:1765-74.CrossRef
17.
go back to reference Chan SY, Brunken RC, Czernin J, Porenta G, Kuhle W, Krivokapich J, et al. Comparison of maximal myocardial blood flow during adenosine infusion with that of intravenous dipyridamole in normal men. J Am Coll Cardiol. 1992;20:979-85.CrossRef Chan SY, Brunken RC, Czernin J, Porenta G, Kuhle W, Krivokapich J, et al. Comparison of maximal myocardial blood flow during adenosine infusion with that of intravenous dipyridamole in normal men. J Am Coll Cardiol. 1992;20:979-85.CrossRef
18.
go back to reference Renaud JM, DaSilva JN, Beanlands RSB, DeKemp RA. Characterizing the normal range of myocardial blood flow with 82rubidium and 13N-ammonia PET imaging. J Nucl Cardiol. 2013;20:578-91.CrossRef Renaud JM, DaSilva JN, Beanlands RSB, DeKemp RA. Characterizing the normal range of myocardial blood flow with 82rubidium and 13N-ammonia PET imaging. J Nucl Cardiol. 2013;20:578-91.CrossRef
19.
go back to reference Sampson UK, Dorbala S, Limaye A, Kwong R, Di Carli MF. Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease. J Am Coll Cardiol. 2007;49:1052-8.CrossRef Sampson UK, Dorbala S, Limaye A, Kwong R, Di Carli MF. Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease. J Am Coll Cardiol. 2007;49:1052-8.CrossRef
21.
go back to reference Kidambi A, Sourbron S, Maredia N, Motwani M, Brown JM, Nixon J, et al. Factors associated with false-negative cardiovascular magnetic resonance perfusion studies: A clinical evaluation of magnetic resonance imaging in coronary artery disease (CE-MARC) substudy. J Magn Reson Imaging JMRI. 2016;43:566-73.CrossRef Kidambi A, Sourbron S, Maredia N, Motwani M, Brown JM, Nixon J, et al. Factors associated with false-negative cardiovascular magnetic resonance perfusion studies: A clinical evaluation of magnetic resonance imaging in coronary artery disease (CE-MARC) substudy. J Magn Reson Imaging JMRI. 2016;43:566-73.CrossRef
22.
go back to reference Ogilby JD, Kegel JG, Heo J, Iskandrian AE. Correlation Between Hemodynamic Changes and Tomographic Sestamibi Imaging During Dipyridamole-Induced Coronary Hyperemia. J Am Coll Cardiol. 1998;31:75-82.CrossRef Ogilby JD, Kegel JG, Heo J, Iskandrian AE. Correlation Between Hemodynamic Changes and Tomographic Sestamibi Imaging During Dipyridamole-Induced Coronary Hyperemia. J Am Coll Cardiol. 1998;31:75-82.CrossRef
23.
go back to reference Kitkungvan D, Johnson NP, Roby AE, Patel MB, Kirkeeide R, Gould KL. Routine clinical quantitative rest stress myocardial perfusion for managing coronary artery disease. JACC Cardiovasc Imaging. 2017;10:565-77.CrossRef Kitkungvan D, Johnson NP, Roby AE, Patel MB, Kirkeeide R, Gould KL. Routine clinical quantitative rest stress myocardial perfusion for managing coronary artery disease. JACC Cardiovasc Imaging. 2017;10:565-77.CrossRef
24.
go back to reference Johnson NP, Gould KL. Regadenoson versus dipyridamole hyperemia for cardiac PET imaging. JACC Cardiovasc Imaging. 2015;8:438-47.CrossRef Johnson NP, Gould KL. Regadenoson versus dipyridamole hyperemia for cardiac PET imaging. JACC Cardiovasc Imaging. 2015;8:438-47.CrossRef
25.
go back to reference Goudarzi B, Fukushima K, Bravo P, Merrill J, Bengel FM. Comparison of the myocardial blood flow response to regadenoson and dipyridamole: A quantitative analysis in patients referred for clinical 82Rb myocardial perfusion PET. Eur J Nucl Med Mol Imaging. 2011;38:1908-16.CrossRef Goudarzi B, Fukushima K, Bravo P, Merrill J, Bengel FM. Comparison of the myocardial blood flow response to regadenoson and dipyridamole: A quantitative analysis in patients referred for clinical 82Rb myocardial perfusion PET. Eur J Nucl Med Mol Imaging. 2011;38:1908-16.CrossRef
26.
go back to reference Pelletier-Galarneau M, deKemp RA, Hunter CRRN, Klein R, Klein M, Ironstone J, et al. Effects of hypercapnia on myocardial blood flow in healthy human subjects. J Nucl Med. 2018;59:100-6.CrossRef Pelletier-Galarneau M, deKemp RA, Hunter CRRN, Klein R, Klein M, Ironstone J, et al. Effects of hypercapnia on myocardial blood flow in healthy human subjects. J Nucl Med. 2018;59:100-6.CrossRef
27.
go back to reference Murthy VL, Bateman TM, Beanlands RS, Berman DS, Borges-Neto S, Chareonthaitawee P, et al. Clinical quantification of myocardial blood flow using PET: Joint position paper of the SNMMI Cardiovascular Council and the ASNC. J Nucl Med. 2018;59:273-93.CrossRef Murthy VL, Bateman TM, Beanlands RS, Berman DS, Borges-Neto S, Chareonthaitawee P, et al. Clinical quantification of myocardial blood flow using PET: Joint position paper of the SNMMI Cardiovascular Council and the ASNC. J Nucl Med. 2018;59:273-93.CrossRef
28.
go back to reference Maddahi J. Properties of an ideal PET perfusion tracer: New PET tracer cases and data. J Nucl Cardiol. 2012;19(Suppl 1):S30-7.CrossRef Maddahi J. Properties of an ideal PET perfusion tracer: New PET tracer cases and data. J Nucl Cardiol. 2012;19(Suppl 1):S30-7.CrossRef
29.
go back to reference Yoshida K, Mullani N, Gould KL. Coronary flow and flow reserve by PET simplified for clinical applications using rubidium-82 or nitrogen-13-ammonia. J Nucl Med. 1996;37:1701-12. Yoshida K, Mullani N, Gould KL. Coronary flow and flow reserve by PET simplified for clinical applications using rubidium-82 or nitrogen-13-ammonia. J Nucl Med. 1996;37:1701-12.
30.
go back to reference Dekemp RA, Declerck J, Klein R, Pan X-B, Nakazato R, Tonge C, et al. Multisoftware reproducibility study of stress and rest myocardial blood flow assessed with 3D dynamic PET/CT and a 1-tissue-compartment model of 82Rb kinetics. J Nucl Med. 2013;54:571-7.CrossRef Dekemp RA, Declerck J, Klein R, Pan X-B, Nakazato R, Tonge C, et al. Multisoftware reproducibility study of stress and rest myocardial blood flow assessed with 3D dynamic PET/CT and a 1-tissue-compartment model of 82Rb kinetics. J Nucl Med. 2013;54:571-7.CrossRef
Metadata
Title
Comparison of two dipyridamole infusion protocols for myocardial perfusion imaging in subjects with low likelihood of significant obstructive coronary artery disease
Authors
Francois Harel, MD, PhD, FRCPC
Vincent Finnerty, MSc
Sébastien Authier, BEng
Matthieu Pelletier-Galarneau, MD, MSc, FRCPC
Publication date
01-10-2020
Publisher
Springer International Publishing
Published in
Journal of Nuclear Cardiology / Issue 5/2020
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-018-01478-x

Other articles of this Issue 5/2020

Journal of Nuclear Cardiology 5/2020 Go to the issue